IQ-AI Limited (GB:IQAI) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
IQ-AI Limited’s subsidiary, Imaging Biometrics, has renewed its distribution agreement with GE HealthCare to expand the reach of its advanced imaging solutions. The agreement will see GE HealthCare selling IB Neuro and IB Delta T1 platforms, which are vital for brain tumor diagnosis and treatment monitoring. This collaboration aims to expedite the adoption of these innovative tools, enhancing healthcare providers’ capabilities and benefiting patients worldwide.
For further insights into GB:IQAI stock, check out TipRanks’ Stock Analysis page.
